eCAM Advance Access published online on April 7, 2005
eCAM, doi:10.1093/ecam/neh081
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Academia Sinica, Taipei
* To whom correspondence should be addressed. SARS-CoV is the causative agent of severe acute respiratory syndrome (SARS). The virally encoded 3C-like protease (3CLPro) has been presumed critical for the viral replication of SARS-CoV in infected host cells. In this study, we screened a natural product library consisting of 720 compounds for inhibitory activity against 3CLPro. Two compounds in the library were found to be inhibitive: tannic acid (IC50 = 3 µM) and 3-isotheaflavin-3-gallate (TF2B) (IC50 = 7 µM). These two compounds belong to a group of natural polyphenols found in tea. We further investigated the 3CLPro-inhibitory activity of extracts from several different types of teas, including green tea, oolong tea, Puer tea and black tea. Our results indicated that extracts from Puer and black tea were more potent than that from green or oolong teas in their inhibitory activities against 3CLPro. Several other known compositions in teas were also evaluated for their activities in inhibiting 3CLPro. We found that caffeine, (-)-epigallocatechin gallte (EGCg), epicatechin (EC), theophylline (TP), catechin (C), epicatechin gallate (ECg) and epigallocatechin (EGC) did not inhibit 3CLPro activity. Only theaflavin-3,3'-digallate (TF3) was found to be a 3CLPro inhibitor. This study has resulted in the identification of new compounds that are effective 3CLPro inhibitors.
Received September 30, 2004
Accepted March 11, 2005
Original Article
Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3)
2 Institute of Biological Chemistry, Academia Sinica, Taipei
3 Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Academia Sinica, Taipei; Department of Chemical Engineering, National Tsing Hua University, Hsinchu, Taiwan
John T.-A. Hsu, E-mail: tsuanhsu{at}nhri.org.tw
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B.-C. Kim, W.-J. Jeong, D. Y. Kim, H.-W. Oh, H. Kim, D.-S. Park, H.-M. Park, and K. S. Bae Paenibacillus pueri sp. nov., isolated from Pu'er tea Int J Syst Evol Microbiol, May 1, 2009; 59(5): 1002 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Bian, A. Masuda, T. Matsuura, M. Ito, K. Okushin, A. G. Engel, and K. Ohno Tannic acid facilitates expression of the polypyrimidine tract binding protein and alleviates deleterious inclusion of CHRNA1 exon P3A due to an hnRNP H-disrupting mutation in congenital myasthenic syndrome Hum. Mol. Genet., April 1, 2009; 18(7): 1229 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Klein, J. Kim, K. Himmeldirk, Y. Cao, and X. Chen Antidiabetes and Anti-obesity Activity of Lagerstroemia speciosa Evid. Based Complement. Altern. Med., December 1, 2007; 4(4): 401 - 407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Ravindranath, T. S. Saravanan, C. C. Monteclaro, N. Presser, X. Ye, S. R. Selvan, and S. Brosman Epicatechins Purified from Green Tea (Camellia sinensis) Differentially Suppress Growth of Gender-Dependent Human Cancer Cell Lines Evid. Based Complement. Altern. Med., June 1, 2006; 3(2): 237 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Cooper eCAM benefits from diversity that derives from CAM Evid. Based Complement. Altern. Med., September 1, 2005; 2(3): 263 - 265. [Full Text] [PDF]
|
|